{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-049197","form_type":"8-K","ticker":"BPTH","cik":"0001133818","company_name":"BIO-PATH HOLDINGS, INC.","filed_at":"2024-04-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.408018+00:00","generated_at":"2026-06-03T15:13:33.552121+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bio-Path Holdings raises $1.2M in registered direct offering and warrants","bullets":["Sold 375,000 shares at $3.225 per share for gross proceeds of $1.2 million.","Concurrent private placement of warrants to purchase 375,000 shares at $3.10 per share.","Net proceeds of ~$1.0M after fees; intended for working capital and general purposes.","Offering expected to close April 19, 2024; H.C. Wainwright acted as placement agent.","Outstanding shares will increase from 1,190,306 to 1,565,306 post-closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-049197","json":"https://secwatch.observer/filing/0001104659-24-049197.json","markdown":"https://secwatch.observer/filing/0001104659-24-049197.md","text":"https://secwatch.observer/filing/0001104659-24-049197.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133818/000110465924049197/0001104659-24-049197-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133818/000110465924049197/tm2412201d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T15:13:33.552121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"51b541fe7daba6300d51911d9819d58f2b18aa83","claim":"BIO-PATH HOLDINGS, INC. entered into Purchase Agreement with certain institutional investors valued at approximately $1.2 million (effective 2024-04-18).","evidence_excerpt":"On April 18, 2024, Bio-Path Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 375,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $3.225 and gross proceeds of approximately $1.2 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133818/000110465924049197/0001104659-24-049197-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors"},{"label":"Value","value":"approximately $1.2 million"},{"label":"Effective","value":"2024-04-18"}],"fact_type":"material_agreement"},{"claim_id":"889b4f1ab9d348baff2ec4a395d0bec05cedb404","claim":"BIO-PATH HOLDINGS, INC. entered into Engagement Letter with H.C. Wainwright & Co., LLC (effective 2024-03-22).","evidence_excerpt":"On March 22, 2024, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (the “Placement Agent”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133818/000110465924049197/0001104659-24-049197-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Effective","value":"2024-03-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}